Latest Cost Reduction News

MAC Copper Limited reported a 10% revenue decline but narrowed its net loss by 25% in HY25, achieving record daily copper production and advancing its acquisition by Harmony Gold.

thl reports a statutory net loss for FY25, driven by impairments, while underlying profit falls 45%. The company maintains dividends and outlines strategic initiatives to restore growth and profitability.

Tourism Holdings Limited reported a statutory net loss in FY25 amid challenging market conditions but remains confident in a strategic turnaround targeting over $100 million in annualised NPAT within four years.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

Inghams Group reported a stable FY25 underlying EBITDA pre AASB 16 at $236.4 million, with strong New Zealand growth offsetting challenges in Australia. The company outlines a cautious but optimistic FY26 outlook, focusing on cost reductions and operational efficiencies.

Inghams Group reported a stable underlying EBITDA of $236.4 million for FY25 despite softer market conditions and customer changes, while guiding for a modest earnings dip in FY26 as cost reduction programs take effect.

Australian Vintage Limited reported a strong FY25 with significant profit growth despite flat revenue, underpinned by innovation and cost-cutting initiatives. The company aims for positive free cash flow in FY26, propelled by global brand expansion and operational efficiencies.

Aerometrex has confirmed Robert Veitch as its new CEO and Managing Director, following a strategic overhaul that delivered $2 million in annual cost savings and boosted its MetroMap revenue stream.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Downer EDI Limited reported a robust FY25 with a 33% rise in underlying NPATA and announced a $230 million share buy-back, underscoring confidence in its transformation and growth outlook. The company’s disciplined portfolio simplification and operational improvements set the stage for steady FY26 performance despite short-term market softness.

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.